ALDEHYDES ARE THE CULPRIT: A UNIFYING MITOCHONDRIAL HYPOTHESIS FOR THE PATHOGENESIS OF ALCOHOLIC AND NON-ALCOHOLIC STEATOHEPATITIS (ASH AND NASH)

被引：0
|
作者：
Lemasters, J. J.
Zhong, Z.
机构：
[1] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2021年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
011
引用
收藏
页码：16A / 16A
页数：1
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [22] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [23] Alcoholic and non-alcoholic steatohepatitis
    Neuman, Manuela G.
    French, Samuel W.
    French, Barbara A.
    Seitz, Helmut K.
    Cohen, Lawrence B.
    Mueller, Sebastian
    Osna, Natalia A.
    Kharbanda, Kusum K.
    Seth, Devanshi
    Bautista, Abraham
    Thompson, Kyle J.
    McKillop, Iain H.
    Kirpich, Irina A.
    McClain, Craig J.
    Bataller, Ramon
    Nanau, Radu M.
    Voiculescu, Mihai
    Opris, Mihai
    Shen, Hong
    Tillman, Brittany
    Li, Jun
    Liu, Hui
    Thomes, Paul G.
    Ganesan, Murali
    Malnick, Steve
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (03) : 492 - 510
  • [24] Alcoholic and non-alcoholic steatohepatitis
    不详
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 266 - 266
  • [25] ESTROGEN DEFICIENCY AND LIPOPOLYSACCHARIDE PLAY ROLES IN THE PATHOGENESIS OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Takahashi, A.
    Okai, K.
    Katsushima, F.
    Monoe, K.
    Kanno, Y.
    Saito, H.
    Abe, K.
    Ohira, H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S499 - S500
  • [26] Biochemical, histologic, and mitochondrial ultrastructural effects of troglitazone in non-alcoholic steatohepatitis (NASH).
    Caldwell, SH
    Hespenheide, EE
    Redick, JA
    Iezzoni, JC
    Battle, EH
    Sheppard, BL
    HEPATOLOGY, 1999, 30 (04) : 528A - 528A
  • [27] Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
    Zhu, Bo
    Chan, Siu-Lung
    Li, Jack
    Li, Kathryn
    Wu, Hao
    Cui, Kui
    Chen, Hong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [28] Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
    Salomone, Federico
    Zelber-Sagi, Shira
    Galvano, Fabio
    Fabbrini, Elisa
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [29] Endotoxins and cytokines in the pathogenesis of non-alcoholic steatohepatitis
    Diehl, AM
    STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 62 - 68
  • [30] Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
    Musso, Giovanni
    Gambino, Roberto
    Cassader, Maurizio
    PROGRESS IN LIPID RESEARCH, 2013, 52 (01) : 175 - 191
12345